4//SEC Filing
ASADORIAN RAFFI 4
Accession 0001209191-22-016242
CIK 0001427925other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:25 PM ET
Size
5.6 KB
Accession
0001209191-22-016242
Insider Transaction Report
Form 4
ASADORIAN RAFFI
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2022-03-03$0.41/sh−7,923$3,223→ 364,205 total
Footnotes (4)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Balance includes non-reportable acquisition of 4,040 shares of Common Stock through the Company's Employee Stock Purchase Plan.
- [F4]On February 14, 2022, the reporting person filed a Form 4 which inadvertently under-reported his holdings in the Issuer by 8 shares. In addition to reporting the current transactions, this Form 4 serves to correct the reporting person's holdings in the Issuer.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001628970
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:25 PM ET
- Size
- 5.6 KB